Brain Imaging Centers Say There Has Been An Increase In Requests From People Who Used Depo-Provera

More people who used Depo-Provera are getting diagnostic scans and neurological evaluations because they are worried about the long-term health of their brains.

Wednesday, August 13, 2025 - Brain imaging institutes all around the US are getting more and more requests for scans from people who once took Depo-Provera, a long-acting birth control shot. Many of these former users were on the drug for years, but now they are looking for MRIs and CT scans since there have been more reports of a possible relationship between Depo-Provera and meningioma, a type of brain tumor. People are asking for more Depo-Provera because they are worried about their health and because there are more lawsuits. Some patients have even called a Depo-Provera brain tumor lawyer to find out what their legal rights are. These worries have become more urgent because of the ongoing flood of Depo-Provera cancer lawsuits. Some women are reporting alarming symptoms including headaches that won't go away, dizziness, or problems with thinking, which is making them ask for brain imaging even without formal referrals. Imaging centers are changing how they take in new patients because there has been a lot of interest, and a lot of it is now specifically about Depo-Provera.

In 2024, the European Medicines Agency (EMA) changed the label on Depo-Provera to add a warning about the higher risk of meningioma that comes with long-term use. There was a lot of evidence indicating women who got the shot for more than five years were far more likely to get this slow-growing tumor. Meningiomas are normally not malignant, but where they are in the brain might cause major difficulties depending on their size and where they are. Doctors are telling those who used to take drugs to be on the lookout for possible signs and to talk to their doctors about any concerns they have. In response, imaging facilities are giving their personnel more training so they can answer these questions and give patients educational resources to assist them in comprehending what scans can find. Researchers are also looking into how progestin, the synthetic hormone in Depo-Provera, might help brain tissue cells grow in an aberrant way. The medical community is also thinking about whether or not to make proactive screening criteria for those who used to use drugs.

As more people learn about the prospective concerns, more women are likely to want brain scans in the future. This trend shows that we need improved screening protocols, more patient education, and maybe even changes to insurance so that scans are covered when they are needed based on medical history. As the number of people who need Depo-Provera rises, hospitals and diagnostic clinics may need to either expand their services or make them more efficient. This is especially true now that new lawsuits are bringing national attention to the issue. Regulators might feel pressure to look again at how long the drug can be safely used and what kind of long-term monitoring should be done. If more research shows a stronger link between Depo-Provera and meningioma, doctors may adjust how they prescribe it and how they talk to patients about it. Until then, both patients and clinicians should keep transparency, informed decision-making, and quick access to diagnostic treatment at the top of their lists.

More Recent Depo Provera Lawsuit News:

Depo Provera Brain Tumor Attorneys Handling Claims Nationwide

We will represent all persons involved in a Depo Provera lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Anyone who has been treated for a meningioma brain tumor and has a history of using Depo Provera for at least a year--or is a family member of such a person--is eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Depo Provera meningioma lawyers will contact you promptly to discuss your case.